332064-94-5,
Fmoc-(R)-3-Amino-5-hexynoic acid,
(3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)hex-5-ynoic Acid,
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hex-5-ynoic acid,
Fmoc-D-beta-homopropargylglycine,
Fmoc-D-?-Homogly(Propargyl)-OH,
Fmoc-D-ss-homopropargylglycine,
SCHEMBL1296652,
DTXSID30426577,
ZINC2385799,
MFCD01860910,
AKOS015900102,
CF-1185,
FCH3592846,
RTR-013910,
AC-22140,
ACM332064945,
PS-12347,
TR-013910,
FT-0679891,
TL80073757,
A-8948,
I14-10550,
(3R)-3-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-5-hexynoic acid,
(3R)-3-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]-5-hexynoic acid,
(3R)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}hex-5-ynoic acid,
(3R)-3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)hex-5-ynoic acid,
CID7009726,
FMOC- -3-AMINO-5-HEXYNOICACID,
5-Hexynoic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (3R)-,